Read More Pharma Industry News FDA grants accelerated approval to AstraZeneca’s Calquence for mantle cell lymphoma treatment AstraZeneca has achieved a significant milestone with the early FDA approval of Calquence (acalabrutinib) for the treatment of… bypharmanewsdailyNovember 1, 2017
